CD163 and type 1 diabetes mellitus: We also found that the down-regulated pathways affected by CD163 included antigen processing and presentation, autoimmune thyroid disease, graft versus host disease, and intestinal pathways immune network for IGA production and type I diabetes mellitus (Figure 7A).